# Food-effect Study of Ecopipam Pharmacokinetics

> **NCT06669091** · PHASE1 · COMPLETED · sponsor: **Emalex Biosciences Inc.** · enrollment: 25 (actual)

## Conditions studied

- Food-effect

## Interventions

- **DRUG:** Ecopipam tablet

## Key facts

- **NCT ID:** NCT06669091
- **Lead sponsor:** Emalex Biosciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-05
- **Primary completion:** 2024-12-22
- **Final completion:** 2024-12-27
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06669091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06669091, "Food-effect Study of Ecopipam Pharmacokinetics". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06669091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*